House of Doge to Be Delisted From Nasdaq, Trading Suspended Nov. 3

House of Doge (Nasdaq: HODO) said in an 8-K filed Monday that Nasdaq's staff has determined to delist its common stock. Trading will be suspended at the opening of business on Nov. 3, 2026, and a Form 25-NSE will be filed with the Securities and Exchange Commission to remove the shares from listing and registration on Nasdaq.

An earlier 8-K filed Oct. 23 described a binding letter of intent for an acquisition, the termination of a Dogecoin license and the replacement of the chief executive and chief financial officers. The Nov. 2 filing is signed by Curtis Hopkins as interim chief executive and interim chief financial officer.

How the bid-price deficiency unfolded

Nasdaq sent a deficiency letter on Sept. 9, 2026, saying the closing bid price had been below $1.00 for 30 consecutive business days. The company was given 180 calendar days, or until March 8, 2027, to regain compliance.

On Oct. 27, the staff said that as of Oct. 26 the closing bid price had been $0.10 or less for ten consecutive trading days, from Oct. 13 through Oct. 26. Under Nasdaq rules, that level for ten days during a compliance period requires a delisting determination, so the staff acted before the March deadline. The determination also notes the company had not regained compliance with the $1.00 requirement.

What the company can do before Nov. 3

The company may appeal to a Nasdaq Hearings Panel, requesting either an oral hearing or one based on written submissions. The request must include a non-refundable $20,000 fee and must reach Nasdaq by 4:00 p.m. Eastern Time on Nov. 3, 2026. A timely request will not stay the suspension of trading.

If the company asks for a hearing, it would be asked to present a plan to regain compliance, which may include a commitment to a reverse stock split. The company said it is evaluating its options, including whether to request a hearing, and expects to file a proxy statement for its annual meeting with a proposal to approve a reverse split. The filing says there is no assurance the company will request a hearing, that the panel will grant continued listing, or that stockholders will approve a reverse split.

Finances going into the delisting

The company reported a net loss of $15.9 million for the fiscal year ended Dec. 31, 2025, wider than the $3.3 million loss a year earlier. For the quarter ended June 30, 2026, it reported revenue of $38 thousand and net income of $4.0 million, compared with a net loss of $12.1 million a year earlier. Diluted earnings per share were $0.05, against a loss of $0.24.

Cash and equivalents, including any restricted cash, were $0.7 million as of June 30, 2026. The 8-K lists the availability of sufficient funds and financing among the risks that could affect the company.

What suspension could mean for shareholders

The company said trading may move to an over-the-counter market, but it cannot assure that a quotation will be available or that an active market will develop. The filing says suspension and delisting could reduce liquidity and the share price, make it harder to raise equity, limit the use of registration statements to sell freely tradable shares, and impair equity incentives for employees.